Testing effectiveness (Phase 2)Study completedNCT04463004
What this trial is testing
Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Who this might be right for
COVID-19Sars-CoV2Pneumonia
Virginia Commonwealth University 2